KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Receivables: 2009-2025

Historic Receivables for Dynavax Technologies (DVAX) over the last 16 years, with Sep 2025 value amounting to $73.3 million.

  • Dynavax Technologies' Receivables fell 2.60% to $73.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $250.1 million, marking a year-over-year increase of 9.42%. This contributed to the annual value of $46.9 million for FY2024, which is 5.33% up from last year.
  • According to the latest figures from Q3 2025, Dynavax Technologies' Receivables is $73.3 million, which was down 0.03% from $73.3 million recorded in Q2 2025.
  • Over the past 5 years, Dynavax Technologies' Receivables peaked at $252.8 million during Q3 2021, and registered a low of $44.5 million during Q4 2023.
  • Its 3-year average for Receivables is $61.4 million, with a median of $56.6 million in 2025.
  • In the last 5 years, Dynavax Technologies' Receivables spiked by 11,627.57% in 2021 and then plummeted by 79.49% in 2023.
  • Over the past 5 years, Dynavax Technologies' Receivables (Quarterly) stood at $178.7 million in 2021, then increased by 21.46% to $217.1 million in 2022, then crashed by 79.49% to $44.5 million in 2023, then grew by 5.33% to $46.9 million in 2024, then dropped by 2.60% to $73.3 million in 2025.
  • Its Receivables stands at $73.3 million for Q3 2025, versus $73.3 million for Q2 2025 and $56.6 million for Q1 2025.